65 related articles for article (PubMed ID: 7490247)
21. Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities.
Serra M; Scotlandi K; Manara MC; Maurici D; Benini S; Sarti M; Nini G; Barbanti-Brodano G; Baldini N
Cytotechnology; 1996; 19(3):253-6. PubMed ID: 8862015
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood.
Chan HS; Thorner PS; Haddad G; Ling V
J Clin Oncol; 1990 Apr; 8(4):689-704. PubMed ID: 1968964
[TBL] [Abstract][Full Text] [Related]
23. Do stem-like cells play a role in drug resistance of sarcomas?
Honoki K
Expert Rev Anticancer Ther; 2010 Feb; 10(2):261-70. PubMed ID: 20132001
[TBL] [Abstract][Full Text] [Related]
24. Pediatric soft tissue sarcomas.
Herzog CE; Stewart JM; Blakely ML
Surg Oncol Clin N Am; 2003 Apr; 12(2):419-47, vii. PubMed ID: 12916462
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance in pediatric oncology.
Kuttesch JF
Invest New Drugs; 1996; 14(1):55-67. PubMed ID: 8880394
[TBL] [Abstract][Full Text] [Related]
26. P-glycoprotein in human sarcoma: evidence for multidrug resistance.
Gerlach JH; Bell DR; Karakousis C; Slocum HK; Kartner N; Rustum YM; Ling V; Baker RM
J Clin Oncol; 1987 Sep; 5(9):1452-60. PubMed ID: 2887642
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.
Jimenez RE; Zalupski MM; Frank JJ; Du W; Ryan JR; Lucas DR
Cancer; 1999 Sep; 86(6):976-81. PubMed ID: 10491523
[TBL] [Abstract][Full Text] [Related]
28. Drug resistance studies using fresh human ovarian carcinoma and soft tissue sarcoma samples.
Coley HM
Keio J Med; 1997 Sep; 46(3):142-7. PubMed ID: 9339643
[TBL] [Abstract][Full Text] [Related]
29. Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.
Fayette J; Blay JY
Curr Opin Oncol; 2005 Jul; 17(4):370-5. PubMed ID: 15933471
[TBL] [Abstract][Full Text] [Related]
30. [Expression of p-glycoprotein in malignant solid human tumors].
Grelewski PG; Bar JK
Ginekol Pol; 2002 Feb; 73(2):133-41. PubMed ID: 12001773
[TBL] [Abstract][Full Text] [Related]
31. Cellular plasticity and drug resistance in sarcoma.
Lin Z; Fan Z; Zhang X; Wan J; Liu T
Life Sci; 2020 Dec; 263():118589. PubMed ID: 33069737
[TBL] [Abstract][Full Text] [Related]
32. Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance.
Vinod BS; Maliekal TT; Anto RJ
Antioxid Redox Signal; 2013 Apr; 18(11):1307-48. PubMed ID: 22871022
[TBL] [Abstract][Full Text] [Related]
33. The question begs--what is the role of P-glycoprotein in normal physiology?
Johnstone RW; Smyth MJ
Drug Resist Updat; 1998; 1(5):340-2. PubMed ID: 17092815
[No Abstract] [Full Text] [Related]
34. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
35. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
[TBL] [Abstract][Full Text] [Related]
36. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma.
Bramwell VH; Morris D; Ernst DS; Hings I; Blackstein M; Venner PM; Ette EI; Harding MW; Waxman A; Demetri GD
Clin Cancer Res; 2002 Feb; 8(2):383-93. PubMed ID: 11839653
[TBL] [Abstract][Full Text] [Related]
38. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
39. Multidrug drug resistance in pediatric sarcomas.
Chan HS; DeBoer G; Haddad G; Ling V
Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
